CN101052393A - 氮杂双环己烷的新型多晶型物 - Google Patents

氮杂双环己烷的新型多晶型物 Download PDF

Info

Publication number
CN101052393A
CN101052393A CNA2005800279269A CN200580027926A CN101052393A CN 101052393 A CN101052393 A CN 101052393A CN A2005800279269 A CNA2005800279269 A CN A2005800279269A CN 200580027926 A CN200580027926 A CN 200580027926A CN 101052393 A CN101052393 A CN 101052393A
Authority
CN
China
Prior art keywords
polymorph form
polymorph
addition salts
azabicyclo
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800279269A
Other languages
English (en)
Chinese (zh)
Inventor
埃里克·J·哈根
凯文·哈洛伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOV Pharmaceutical Inc
Original Assignee
DOV Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOV Pharmaceutical Inc filed Critical DOV Pharmaceutical Inc
Publication of CN101052393A publication Critical patent/CN101052393A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CNA2005800279269A 2004-08-18 2005-08-17 氮杂双环己烷的新型多晶型物 Pending CN101052393A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92074804A 2004-08-18 2004-08-18
US10/920,748 2004-08-18

Publications (1)

Publication Number Publication Date
CN101052393A true CN101052393A (zh) 2007-10-10

Family

ID=35968183

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800279269A Pending CN101052393A (zh) 2004-08-18 2005-08-17 氮杂双环己烷的新型多晶型物

Country Status (14)

Country Link
EP (1) EP1786417A4 (de)
JP (1) JP2008510715A (de)
KR (3) KR20130108489A (de)
CN (1) CN101052393A (de)
AU (1) AU2005277351A1 (de)
BR (1) BRPI0515193A (de)
CA (1) CA2619817A1 (de)
IL (1) IL181185A (de)
MX (1) MX2007001827A (de)
NO (1) NO20071372L (de)
NZ (1) NZ589033A (de)
RU (1) RU2007109817A (de)
WO (1) WO2006023659A2 (de)
ZA (1) ZA200701570B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
EP2719384B1 (de) 2005-07-27 2018-08-08 Otsuka America Pharmaceutical, Inc. Neue 1-naphthyl-3-azabicyclo [3.1.0] hexan: Herstellung und Verwendung zur Behandlung neuropsychiatrischer Erkrankungen
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
AU2011336318A1 (en) * 2010-12-03 2013-07-04 Euthymics Bioscience, Inc. Preparation and use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters
EP2994129A4 (de) * 2013-05-07 2017-01-25 Euthymic Bioscience, Inc. Verwendung von (+)-1-(3,4-dichlorphenyl)-3-azabicyclo-[3.1.0]-hexan zur behandlung von sucht- und alkoholbedingten erkrankungen
KR101567003B1 (ko) 2013-12-27 2015-11-06 경희대학교 산학협력단 골편 고정장치 및 골편 절단을 위한 드릴 어셈블리
SI3597189T1 (sl) 2015-06-17 2022-08-31 Otsuka America Pharmaceutical, Inc. Kristalinične spojine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435419A (en) * 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent

Also Published As

Publication number Publication date
NO20071372L (no) 2007-05-18
CA2619817A1 (en) 2006-03-02
EP1786417A4 (de) 2009-05-20
IL181185A0 (en) 2007-07-04
KR20130108489A (ko) 2013-10-02
MX2007001827A (es) 2007-04-23
KR20070054208A (ko) 2007-05-28
RU2007109817A (ru) 2008-09-27
AU2005277351A1 (en) 2006-03-02
WO2006023659A3 (en) 2006-12-07
KR20130004370A (ko) 2013-01-09
JP2008510715A (ja) 2008-04-10
EP1786417A2 (de) 2007-05-23
NZ589033A (en) 2012-06-29
ZA200701570B (en) 2008-08-27
BRPI0515193A (pt) 2008-07-08
WO2006023659A2 (en) 2006-03-02
IL181185A (en) 2012-10-31

Similar Documents

Publication Publication Date Title
CN101052393A (zh) 氮杂双环己烷的新型多晶型物
CN1845674A (zh) 一种二肽基肽酶iv抑制剂的磷酸盐新晶体
CN1898233A (zh) 罗苏伐他汀( e )－7－[4－(4－氟苯基)－6－异丙基－2－[甲基(甲磺酰基)氨基 ]嘧啶－5－基] (3r , 5s)－3, 5－二羟庚－6－烯酸钙盐及其结晶中间体的制备方法
CN101039910A (zh) 适合制备药物组合物的多奈哌齐盐
TW201524507A (zh) 雜環化合物及其用途
CN1434708A (zh) 新的盐酸舍曲林多晶型物、其制备方法、含有它们的组合物和应用它们的方法
US9770436B2 (en) Polymorphs of azabicyclohexane
CN1835936A (zh) 用于治疗阿尔茨海默氏病的大环β－分泌酶抑制剂
US9856217B2 (en) Crystalline compounds
CN1217720A (zh) 苯并呋喃基衍生物及其应用
CN1976894A (zh) 阿托莫西汀盐酸盐的多形体
CN1976921A (zh) (3r)－1－(2－甲基丙氨酰－d－色氨酰)－3－(苯甲基)－3－哌啶羧酸1,2,2－三甲基酰肼的晶形
CN1308307C (zh) 假多晶型的卡维地洛
CN1056496A (zh) 麦角灵-8-羧基酰胺的改进及其有关方面
CN1147297C (zh) 新型七叶亭衍生物及医药组合物
MX2011010658A (es) Inhibidor de la recaptacion de serotonina y norepinefrina.
JP2018527363A (ja) リナグリプチン結晶形及びこの製造方法
CN1359389A (zh) 美拉加川的实质性结晶形式
CN1114592C (zh) 奥沙奈丹的晶型
CN1826318A (zh) 稳定的替加色罗马来酸氢盐变体
CN1880294A (zh) 右酮洛芬氨丁三醇的多晶型、其制备方法和包含它的组合物
CA2536149C (en) Stable polymorph of bifeprunox mesilate(7-(4-(1,1'-biphenyl)-3-ylmethyl)-1-piperazinyl)-2(3h)-benzoxazolone monomethanesulfonate)
CN1612874A (zh) 罗格列酮乙二磺酸盐和它们作为抗糖尿病药物的用途
CN1361776A (zh) 新的氟化咪唑啉苯并二噁烷,其制备及其治疗用途
EA030553B1 (ru) Тапентадола малеат и его кристаллические формы

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1107255

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20071010

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1107255

Country of ref document: HK